(Q38867891)

English

Type I interferon as a biomarker in autoimmunity and viral infection: a leukocyte subset-specific analysis unveils hidden diagnostic options

scientific article published on 29 March 2017

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 September 2017

Type I interferon as a biomarker in autoimmunity and viral infection: a leukocyte subset-specific analysis unveils hidden diagnostic options (English)

1 reference

Europe PubMed Central

7 September 2017

0 references

Markus Peck-Radosavljevic

6

object named as

Markus Peck-Radosavljevic

0 references

Gerd-Rüdiger Burmester

13

object named as

Gerd-Rüdiger Burmester

0 references

Andreas Grützkau

17

object named as

Andreas Grützkau

0 references

16

object named as

Falk Hiepe

0 references

Andreas Radbruch

12

object named as

Andreas Radbruch

1 reference

Europe PubMed Central

7 September 2017

14

object named as

Paul A Lyons

1 reference

Europe PubMed Central

7 September 2017

object named as

Robert Biesen

18

0 references

author name string

Romy Strauß

1

1 reference

Europe PubMed Central

7 September 2017

Thomas Rose

2

1 reference

Europe PubMed Central

7 September 2017

Shaun M Flint

3

1 reference

Europe PubMed Central

7 September 2017

Jens Klotsche

4

1 reference

Europe PubMed Central

7 September 2017

Thomas Häupl

5

1 reference

Europe PubMed Central

7 September 2017

Taketoshi Yoshida

7

1 reference

Europe PubMed Central

7 September 2017

Chieko Kyogoku

8

1 reference

Europe PubMed Central

7 September 2017

Alexandra Flechsig

9

1 reference

Europe PubMed Central

7 September 2017

Amy M Becker

10

1 reference

Europe PubMed Central

7 September 2017

Kathryn H Dao

11

1 reference

Europe PubMed Central

7 September 2017

Laurie S Davis

15

1 reference

Europe PubMed Central

7 September 2017

Andreas Grützkau

17

1 reference

Europe PubMed Central

7 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

29 March 2017

1 reference

Europe PubMed Central

7 September 2017

Journal of Molecular Medicine

1 reference

Europe PubMed Central

7 September 2017

95

1 reference

Europe PubMed Central

7 September 2017

7

1 reference

Europe PubMed Central

7 September 2017

753-765

1 reference

Europe PubMed Central

7 September 2017

https://scigraph.springernature.com/pub.10.1007/s00109-017-1515-7

0 references

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

1 reference

https://api.crossref.org/works/10.1007%2FS00109-017-1515-7

21 January 2018

Interferon and granulopoiesis signatures in systemic lupus erythematosus blood

1 reference

https://api.crossref.org/works/10.1007%2FS00109-017-1515-7

21 January 2018

Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00109-017-1515-7

21 January 2018

Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS00109-017-1515-7

21 January 2018

Longitudinal expression of type I interferon responsive genes in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS00109-017-1515-7

21 January 2018

Use of type I interferon-inducible mRNAs as pharmacodynamic markers and potential diagnostic markers in trials with sifalimumab, an anti-IFNα antibody, in systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1007%2FS00109-017-1515-7

21 January 2018

Safety and pharmacodynamics of rontalizumab in patients with systemic lupus erythematosus: results of a phase I, placebo-controlled, double-blind, dose-escalation study.

1 reference

https://api.crossref.org/works/10.1007%2FS00109-017-1515-7

21 January 2018

Sifalimumab, a human anti-interferon-α monoclonal antibody, in systemic lupus erythematosus: a phase I randomized, controlled, dose-escalation study

1 reference

https://api.crossref.org/works/10.1007%2FS00109-017-1515-7

21 January 2018

Down-regulation of interferon signature in systemic lupus erythematosus patients by active immunization with interferon α-kinoid

1 reference

https://api.crossref.org/works/10.1007%2FS00109-017-1515-7

21 January 2018

A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE).

1 reference

https://api.crossref.org/works/10.1007%2FS00109-017-1515-7

21 January 2018

Interferon-induced 2'-5' adenylate synthetase in vivo and interferon production in vitro by lymphocytes from systemic lupus erythematosus patients with and without circulating interferon

1 reference

https://api.crossref.org/works/10.1007%2FS00109-017-1515-7

21 January 2018

IFNα and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS00109-017-1515-7

21 January 2018

Association of endogenous anti-interferon-α autoantibodies with decreased interferon-pathway and disease activity in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS00109-017-1515-7

21 January 2018

Immune Interferon in the Circulation of Patients with Autoimmune Disease

1 reference

https://api.crossref.org/works/10.1007%2FS00109-017-1515-7

21 January 2018

Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies

1 reference

https://api.crossref.org/works/10.1007%2FS00109-017-1515-7

21 January 2018

Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study

1 reference

https://api.crossref.org/works/10.1007%2FS00109-017-1515-7

21 January 2018

Dissecting interferon-induced transcriptional programs in human peripheral blood cells

1 reference

https://api.crossref.org/works/10.1007%2FS00109-017-1515-7

21 January 2018

Cell-specific type I IFN signatures in autoimmunity and viral infection: what makes the difference?

1 reference

https://api.crossref.org/works/10.1007%2FS00109-017-1515-7

21 January 2018

Novel expression signatures identified by transcriptional analysis of separated leucocyte subsets in systemic lupus erythematosus and vasculitis

1 reference

https://api.crossref.org/works/10.1007%2FS00109-017-1515-7

21 January 2018

SLE peripheral blood B cell, T cell and myeloid cell transcriptomes display unique profiles and each subset contributes to the interferon signature

1 reference

https://api.crossref.org/works/10.1007%2FS00109-017-1515-7

21 January 2018

Memory B and memory plasma cells

1 reference

https://api.crossref.org/works/10.1007%2FS00109-017-1515-7

21 January 2018

The management of peripheral blood cytopenias in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS00109-017-1515-7

21 January 2018

Rapid suppression of hematopoiesis by standard or pegylated interferon-alpha.

1 reference

https://api.crossref.org/works/10.1007%2FS00109-017-1515-7

21 January 2018

Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1007%2FS00109-017-1515-7

21 January 2018

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS00109-017-1515-7

21 January 2018

Gene expression analysis of human red blood cells

1 reference

https://api.crossref.org/works/10.1007%2FS00109-017-1515-7

21 January 2018

Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00109-017-1515-7

21 January 2018

Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia

1 reference

https://api.crossref.org/works/10.1007%2FS00109-017-1515-7

21 January 2018

INTERFEROME: the database of interferon regulated genes

1 reference

https://api.crossref.org/works/10.1007%2FS00109-017-1515-7

21 January 2018

Low density neutrophils in patients with systemic lupus erythematosus, rheumatoid arthritis, and acute rheumatic fever

1 reference

https://api.crossref.org/works/10.1007%2FS00109-017-1515-7

21 January 2018

A flow cytometric method for determination of the interferon receptor IFNAR2 subunit in peripheral blood leukocyte subsets

1 reference

https://api.crossref.org/works/10.1007%2FS00109-017-1515-7

21 January 2018

MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjogren's syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FS00109-017-1515-7

21 January 2018

Plasmacytoid dendritic cells, interferon signaling, and FcγR contribute to pathogenesis and therapeutic response in childhood immune thrombocytopenia.

1 reference

https://api.crossref.org/works/10.1007%2FS00109-017-1515-7

21 January 2018

Gene expression patterns in blood leukocytes discriminate patients with acute infections

1 reference

https://api.crossref.org/works/10.1007%2FS00109-017-1515-7

21 January 2018

Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans

1 reference

https://api.crossref.org/works/10.1007%2FS00109-017-1515-7

21 January 2018

Deconvolution of blood microarray data identifies cellular activation patterns in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS00109-017-1515-7

21 January 2018

Monocyte surface expression of Fcgamma receptor RI (CD64), a biomarker reflecting type-I interferon levels in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS00109-017-1515-7

21 January 2018

Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies

1 reference

https://api.crossref.org/works/10.1007%2FS00109-017-1515-7

21 January 2018

Type I interferonopathies: a novel set of inborn errors of immunity

1 reference

https://api.crossref.org/works/10.1007%2FS00109-017-1515-7

21 January 2018

STING-Associated Vasculopathy with Onset in Infancy — A New Interferonopathy

1 reference

https://api.crossref.org/works/10.1007%2FS00109-017-1515-7

21 January 2018

Enhanced expression of interferon-inducible protein-10 correlates with disease activity and clinical manifestations in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS00109-017-1515-7

21 January 2018

Accelerated Fas-mediated apoptosis of monocytes and maturing macrophages from patients with systemic lupus erythematosus: relevance to in vitro impairment of interaction with iC3b-opsonized apoptotic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/28357476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sialic acid-binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/28357476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of Potential Pharmacodynamic and Diagnostic Markers for Anti-IFN-α Monoclonal Antibody Trials in Systemic Lupus Erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/28357476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MX homologous protein in mononuclear cells from patients with systemic lupus erythematosus.

1 reference

https://pubmed.ncbi.nlm.nih.gov/28357476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monocyte CD64 expression as a novel biomarker for the disease activity of systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/28357476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study

1 reference

https://pubmed.ncbi.nlm.nih.gov/28357476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiple interferons in the circulation of patients with systemic lupus erythematosus and vasculitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/28357476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of association between the interferon-alpha signature and longitudinal changes in disease activity in systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/28357476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00109-017-1515-7

1 reference

Europe PubMed Central

7 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

7 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38867891&oldid=2036309444"